Encapsulation of IL-12 With an Ultra pH-sensitive Tumor Delivery Platform to Improve Tolerability & Promotes Antitumor Response

Time: 2:30 pm
day: Conference Day Two


  • Overcoming narrow therapeutic indexes like IL-12 through targeted delivery
  • Using ON-BOARD ultra-pH sensitive micelles to encapsulate IL-12 for safe delivery to tumor
  • The ON-BOARD micelle’s tumor specificity has been clinically validated by pegsitacianine an intraoperative cancer imaging agent based on the same micelle technology